Market Research Logo

Pharmaceutical and Biotechnology Construction Sector Report - UK 2018-2022

Pharmaceutical and Biotechnology Construction Sector Report - UK 2018-2022

The 4th edition of the 'Pharmaceutical & Biotechnology Construction Sector Report - UK 2018-2022' focuses on the market size, value and activity in the Pharmaceutical, Medical Technology, Medical and Industrial Biotechnology sectors in the UK, the key players and geographical areas of manufacturing and R&D concentration.


  • INTRODUCTION
    • Sources of Information
  • SUMMARY AND MARKET PROSPECTS
    • Summary
    • UK Pharmaceuticals Sector
  • ECONOMIC ENVIRONMENT
    • GDP
      • Table GDP Data – 2015-2018 – Key Constituent Elements
    • Inflation & Interest Rates
    • Unemployment
    • Household Consumption
    • Housing & Construction
    • Sterling
      • Table Exchange Rate Fluctuations 2014-2020 - Sterling to The Dollar, And The Euro, Spot Rates
    • Population Profile
    • Conclusions
  • CONSTRUCTION ACTIVITY IN THE UK PHARMACEUTICAL AND BIOTECHNOLOGY SECTORS
    • Construction Industry
      • Overall Construction Industry
      • Non-Domestic Construction
    • Definition – Pharmaceuticals and Biotechnology
    • Market Size
      • Current Situation
      • Market Prospects
      • Construction Pipeline
        • Table UK Science and Research Projects: Forward Construction Pipeline
    • Capital Expenditure in the Pharmaceutical Sector
    • Science Parks / University Innovation Campuses
      • Table UK Science Parks – Size, Geographical Spread, Sectors and Key Partners
    • Enterprise Zones
    • Construction Issues in the Pharmaceutical Industry
      • Construction Costs
      • Contamination Control Issues
        • Table Airborne Particulate Cleanliness Classes for Cleanrooms (Based on ISO 14644-1)
  • CONSTRUCTION CAPABILITY AND SUPPLY CHAIN
    • Overview of the Supply Chain
    • Construction Consultants and Contractors
    • Specialist Cleanroom Construction, Supply and Services
  • PHARMACEUTICAL INDUSTRY MARKET SIZE AND OVERVIEW
    • Market Definition, Size and Value
      • Global Pharmaceutical Market
      • UK Pharmaceutical Market
      • Biopharmaceutical Sector
      • Medical Technology Sector
      • Digital Health Sector
      • Genomics Sector
      • Location of Biopharmaceutical Manufacturing Sites
        • Table Biopharmaceutical / Medical Technology Sectors: Major Companies and Geographical Location of Facilities in the UK - Manufacturing, R&D, And Packaging & Logistics
    • Pharmaceutical / Biotechnology Clusters
      • Oxfordshire BioCluster
      • London, Cambridge and Stevenage BioClusters
      • Regional Concentration of Pharmaceutical Manufacturing/R&D
      • Future of Pharmaceutical Manufacturing Operations in the UK
    • Value of Pharmaceutical Industry to the UK Economy
      • UK Trade in Pharmaceuticals
    • Sales of Pharmaceutical Drugs to the NHS
    • Pharmaceutical R&D in the UK
      • Government Funding for Science R&D
        • Table Government Resource Funding for Science and Research 2016-2020 by Funding Programme (£m)
        • Table Government Capital Funding for Science and Research 2016-2020 by Funding Programme (£m)
      • Pharmaceutical Company Investment in R&D
        • Table Top 25 Pharmaceutical and Biotechnology Companies by Global R&D Spend 2015 (£bn and by % of Turnover)
      • R&D Pipeline
        • Table Top 20 Global Pharmaceutical and Biotechnology Companies by Drug Pipeline Size in 2015 and 2016
    • Market Drivers and Key Issues in the Pharmaceutical Industry
      • Key General Issues Facing the Pharmaceutical Sector
      • Future of the UK Pharmaceutical Sector
  • LEADING COMPANIES IN THE PHARMACEUTICAL & BIOTECHNOLOGY SECTORS
    • Overview
    • Pharmaceutical Company League Tables
      • Global
        • Table Top 20 Global Pharmaceutical Companies by Market Share (%) 2015
      • UK
        • Table Top 10 Pharmaceutical Companies Market Share (%) 2015
    • Company Profiles
      • AbbVie
        • Table AbbVie – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
      • AstraZeneca
        • Table AstraZeneca – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
      • Boehringer Ingelheim
        • Table Boehringer Ingelheim – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations
      • GSK
        • Table GSK– Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations
      • Johnson & Johnson
        • Table Johnson & Johnson – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
      • Merck
        • Table Merck – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
      • Novartis
        • Table Novartis – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
      • Pfizer
        • Table Pfizer– Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
      • Roche
        • Table Roche – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
      • Sanofi
        • Table Sanofi – Key Operating and Financial Summary Data (Turnover, Capex, R&D, Principal Activities, Key UK Locations)
    • Other Pharmaceutical/Biotechnology Companies
      • Biotechnology – Therapeutics/Diagnostics
      • Biotechnology R&D
      • Pharmaceutical

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report